Contamination in pharmaceutical manufacturing is a pressing issue, jeopardizing public health, trust in healthcare, and the industry’s regulatory compliance. Contaminants, whether physical, chemical, or biological can enter drugs during production, posing risks of illness, injury, or even death. High-profile incidents, such as nitrosamine impurities and heparin contamination, have highlighted systemic vulnerabilities and prompted regulatory scrutiny​​. Contamination Sources a

Statistics on pharmaceutical product recalls due to contamination from 2000 to 2024 reveal a growing concern for public health and safety.